About Bionavis
Bionavis is a Healthcare company based in Tampere (Finland) founded in 2006. It offers instruments and services for advanced surface science and research applications. It operates on a B2B model in Healthcare and Technology sectors. Bionavis offers products and services including MP-SPR, QCMD, and Sensor slides. Its focus areas include Biotech, Drug Development, Molecular Interactions and Scientific Instruments. Its legal entity is BioNavis Ltd.
Company details
BioNavis Ltd, based in Tampere, Finland, develops and supplies innovative instruments like MP-SPR and QCMD for precise surface interactions and nanolayer analysis. They provide services for applications in molecular interactions, drug development, biosensors, and biomaterials research. Serving universities and research institutions, their technology supports studies in nanoparticles and electrochemistry, enabling advanced scientific discoveries.
- Headquarters Tampere, Finland
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website bionavis.com
- Social LinkedIn Facebook
- Legal Name Bionavis Ltd
- Latest Funding Round$36.63K (USD), Grant
Mar 2019
- Investors
Products & Services of Bionavis
Bionavis offers a comprehensive portfolio of products and services, including MP-SPR, QCMD, and Sensor slides.
Device for measuring surface plasmon resonance in research.
System for quartz crystal microbalance with dissipation analysis.
Components for surface interaction measurements in experiments.
Funding Insights of Bionavis
- Total Rounds 1
- Last Round Grant — $36,631
- First Round $36,631
(Mar 2019)
- Investors Count 1
All 1 funding rounds of Bionavis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | $36,631 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Bionavis
Bionavis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Bionavis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bionavis
2 dated milestones of Bionavis across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Bionavis is founded.
- Funding First funding round of $37K.
Web traffic of Bionavis
Websites that share an audience with Bionavis (bionavis.com).
Websites whose visitors overlap most with Bionavis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biosensingusa.com | 100% | 3.5K | #4,933,437 | View details | |
| biacore.com | 61% | View details | |||
| biolinscientific.com | 45% | 72.1K | #524,494 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bionavis
Bionavis was founded in 2006 and raised its 1st funding round 13 years after it was founded.
Bionavis is headquartered in Tampere, Finland.
BioNavis Ltd, based in Tampere, Finland, develops and supplies innovative instruments like MP-SPR and QCMD for precise surface interactions and nanolayer analysis. They provide services for applications in molecular interactions, drug development, biosensors, and biomaterials research. Serving universities and research institutions, their technology supports studies in nanoparticles and electrochemistry, enabling advanced scientific discoveries.
Bionavis offers MP-SPR, QCMD, and Sensor slides.
Bionavis has 1 investor. Key investors include European Union.
Bionavis operates through Bionavis Ltd.